Susquehanna International Group
MED icon

Susquehanna International Group’s Medifast MED Stock Holding History

Susquehanna International Group’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-70,600
Closed -$992K – 13290
2025
Q2 		$992K Sell
70,600
-28,900
-29% -$380K ﹤0.01% 7444
2025
Q1 		$1.34M Buy
99,500
+27,400
+38% +$412K ﹤0.01% 6507
2024
Q4 		$1.27M Sell
72,100
-7,100
-9% -$132K ﹤0.01% 6386
2024
Q3 		$1.52M Sell
79,200
-19,000
-19% -$366K ﹤0.01% 5887
2024
Q2 		$2.14M Buy
98,200
+800
+0.8% +$21.3K ﹤0.01% 4972
2024
Q1 		$3.73M Buy
97,400
+40,800
+72% +$1.98M ﹤0.01% 4127
2023
Q4 		$3.8M Sell
56,600
-29,700
-34% -$2.07M ﹤0.01% 4181
2023
Q3 		$6.46M Buy
86,300
+35,300
+69% +$3.13M ﹤0.01% 3131
2023
Q2 		$4.7M Buy
51,000
+8,700
+21% +$775K ﹤0.01% 3644
2023
Q1 		$4.39M Buy
42,300
+13,400
+46% +$1.49M ﹤0.01% 3651
2022
Q4 		$3.33M Buy
28,900
+13,000
+82% +$1.51M ﹤0.01% 3848
2022
Q3 		$1.72M Sell
15,900
-5,500
-26% -$788K ﹤0.01% 5251
2022
Q2 		$3.86M Sell
21,400
-11,600
-35% -$2.08M ﹤0.01% 3627
2022
Q1 		$5.64M Sell
33,000
-2,300
-7% -$434K ﹤0.01% 3438
2021
Q4 		$7.39M Sell
35,300
-2,500
-7% -$517K ﹤0.01% 3129
2021
Q3 		$7.28M Buy
37,800
+9,300
+33% +$2.29M ﹤0.01% 3338
2021
Q2 		$8.06M Buy
28,500
+6,300
+28% +$1.71M ﹤0.01% 3227
2021
Q1 		$4.7M Sell
22,200
-7,900
-26% -$1.89M ﹤0.01% 4019
2020
Q4 		$5.91M Sell
30,100
-6,000
-17% -$1.06M ﹤0.01% 3171
2020
Q3 		$5.94M Sell
36,100
-30,800
-46% -$5.07M ﹤0.01% 2831
2020
Q2 		$9.28M Sell
66,900
-22,400
-25% -$2.06M ﹤0.01% 2221
2020
Q1 		$5.58M Sell
89,300
-188,400
-68% -$17.2M ﹤0.01% 2439
2019
Q4 		$30.4M Buy
277,700
+148,500
+115% +$14.4M 0.01% 1110
2019
Q3 		$13.4M Buy
129,200
+37,900
+42% +$4.07M ﹤0.01% 1682
2019
Q2 		$11.7M Buy
91,300
+60,900
+200% +$8.46M ﹤0.01% 1737
2019
Q1 		$3.88M Buy
30,400
+14,400
+90% +$1.83M ﹤0.01% 2770
2018
Q4 		$2M Sell
16,000
-122,500
-88% -$21M ﹤0.01% 3521
2018
Q3 		$30.7M Buy
138,500
+85,200
+160% +$17.3M 0.01% 999
2018
Q2 		$8.54M Buy
53,300
+33,100
+164% +$4.23M ﹤0.01% 2103
2018
Q1 		$1.89M Buy
20,200
+14,800
+274% +$1.11M ﹤0.01% 4017
2017
Q4 		$377K Buy
+5,400
New +$358K ﹤0.01% 7169
2017
Q3 		– Sell
-10,500
Closed -$435K – 9305
2017
Q2 		$435K Buy
+10,500
New +$456K ﹤0.01% 6903
2015
Q1 		– Sell
-6,900
Closed -$231K – 9703
2014
Q4 		$231K Sell
6,900
-33,600
-83% -$1.05M ﹤0.01% 8578
2014
Q3 		$1.33M Buy
40,500
+9,300
+30% +$285K ﹤0.01% 5365
2014
Q2 		$949K Sell
31,200
-143,900
-82% -$4.48M ﹤0.01% 6154
2014
Q1 		$5.09M Buy
175,100
+140,400
+405% +$3.76M ﹤0.01% 2862
2013
Q4 		$907K Sell
34,700
-27,000
-44% -$692K ﹤0.01% 5677
2013
Q3 		$1.66M Sell
61,700
-8,400
-12% -$225K ﹤0.01% 4424
2013
Q2 		$1.81M Buy
+70,100
New +$1.84M ﹤0.01% 4059

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Susquehanna International Group's MED Position: Q3 2025 in Review

Susquehanna International Group sold out of Medifast (MED) in Q3 2025, closing a stake of 29,501 shares — an estimated $412K sold.

Susquehanna International Group first reported a position in MED in Q3 2013 and held it in 37 quarters. The position peaked at $4.7M in Q2 2024. 123 funds tracked by Wall St. Rank hold MED as of Q3 2025.

  • Susquehanna International Group reported no remaining Medifast position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 29,501 Medifast shares in Q3 2025, an estimated $412K.
  • Susquehanna International Group first reported a position in Medifast in Q3 2013 and held it in 37 quarters.
  • Susquehanna International Group's Medifast position peaked at $4.7M in Q2 2024.
  • 123 funds tracked by Wall St. Rank held Medifast as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.